Oncology & Cancer

Researchers uncover aberrant natural killer cell subtype

A team led by Prof. Tian Zhigang and Prof. Peng Hui from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS), in collaboration with Prof. Zhang Zemin from Peking University, have ...

Oncology & Cancer

Measuring cancer cell state can reveal drug susceptibility

Over the past few decades, scientists have made great strides in understanding the genetic mutations that can drive cancer. For some types of cancer, these discoveries have led to the development of drugs that target specific ...

Oncology & Cancer

Protein in blood exerts natural anti-cancer protection

Researchers from Thomas Jefferson University's Kimmel Cancer Center have discovered that decorin, a naturally occurring protein that circulates in the blood, acts as a potent inhibitor of tumor growth modulating the tumor ...

Oncology & Cancer

The role of p53 as a target for novel cancer therapies

The p53 tumor suppressor protein is encoded by TP53, the most frequently mutated gene in cancer. A review article published in Nature Reviews Clinical Oncology by Professor Klas G Wiman and colleagues at the Department of ...

page 35 from 40